Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Reviews in Cardiovascular MedicineOpen Access

Transcoronary Sinus Therapy for Coronary Microvascular Dysfunction

View Full Paper
Ask AI
Bookmark
Share

Authors

JRJingjing RaoYWYue WangLTLina Tan

Discussion

Loading...

Member takes

Overview

Observational analysis shows potential benefits of coronary sinus therapies for coronary microvascular dysfunction, suggesting alternative treatments for patients unable to undergo revascularization.

Key Points

  • Coronary sinus interventions can benefit 70–80% of patients with refractory angina and microvascular disease, offering a new treatment pathway.
  • A randomized trial showed no difference in infarct size reduction between pressure-controlled coronary sinus occlusion and standard intervention methods.
  • Coronary microvascular disease reduces exercise tolerance and worsens clinical symptoms, impacting patient quality of life significantly.
  • The integration of coronary venous therapies addresses challenges in managing microvascular obstruction in patients post-revascularization.

Cite This Study

Rao et al. (2025) studied this question.

synapsesocial.com/papers/68c23d3ab210217d6478d0d3https://doi.org/10.31083/rcm38565
View Full Paper
Ask AI
Bookmark
Share